Accepted: 19 May 2022
First Online: 30 June 2022
: K.F.C. has received honoraria for participating on Advisory Board meetings of GSK, AstraZeneca, Novartis, Merck, Nocion, Shionogi and Reckitt Benckiser and on the Scientific Advisory Board of the Clean Breathing Institute supported by GSK Health Care Consumer Products. He has also been remunerated for speaking engagements by AstraZeneca, Novartis and Merck. L.M. reports honoraria from Chiesi, GSK, Merck, NeRRe Therapeutics, and Shionogi Inc.; grant support from Merck; and other support from AstraZeneca, Boehringer Ingelheim, Chiesi and Reckitt Benckiser. W.-J.S. declares grants from Merck and AstraZeneca, consulting fees from Merck, AstraZeneca, Shionogi and GSK, and lecture fees from Merck, AstraZeneca, GSK and Novartis. A.B.C. reports fees to her institution as IDMC Member of an unlicensed vaccine (GSK), an unlicensed molecule for chronic cough (Merck), IDMC Member of an unlicensed monoclonal antibody (AstraZeneca) and personal fees from being an author of two Up-to-date chapters. K.L. has received honoraria from AstraZeneca, Chiesi, Circassia, Daiichi Sankyo (China), GSK, Merck, Shionogi Inc. and Novartis; grant and other support from AstraZeneca, Chiesi, Circassia, Daiichi Sankyo (China), GSK and Merck. B.J.C. has received honoraria from Merck, GSK, Nocion, Axalbion, Menlo and Attenua, and grant support from Site One and Merck. S.S.B. reports honoraria from Merck, Bellus Health, Bayer, Shionogi, NeRRe, Menlo, Boehringer Ingelheim and Reckitt Benckiser. J.A.S. is an inventor on a patent describing methods for detecting cough from sound recordings, licensed to Vitalograph Ltd. J.A.S. has received funding for consultancy and research funds from Afferent Pharmaceuticals, Merck Inc., Bayer, Bellus, GSK, Xention Ltd, Ario Pharma Ltd, Glenmark, Almirall, AstraZeneca, Axalbion, Patara, Verona Pharma, NeRRe Pharmaceuticals, Menlo Pharmaceuticals and Attenua Inc. S.B.M. declares honoraria from Merck, NeRRe Therapeutics, Reckitt Benckiser and Bellus Health and grant support from Merck and Bellus Health. None of the disclosed entities above had any involvement in the conceptualization, design, data collection, analysis, decision to publish or preparation of the manuscript.
Free to read: This content has been made available to all.